Management of Pancreatic Duct and Bile Duct Enlargement

Diagnostic Evaluation

The European Society of Gastrointestinal Endoscopy recommends initial assessment with transabdominal ultrasound and liver function tests for all patients with suspected dilated pancreatic and/or bile ducts 2, 1
The British Society of Gastroenterology suggests that normal results do not exclude pathology if clinical suspicion remains high, and further investigation is warranted 2
The American Gastroenterological Association recommends that for patients over 40 years with unexplained pancreatic duct dilation, CT or endoscopic ultrasound should be performed to rule out underlying pancreatic malignancy 3
The World Journal of Emergency Surgery suggests that magnetic resonance cholangiopancreatography is preferred in pregnant women and children due to lack of radiation exposure 4

The European Society of Gastrointestinal Endoscopy recommends ERCP with biliary sphincterotomy and complete stone extraction as the first-line treatment 2, 1
The British Society of Gastroenterology suggests that if complete stone extraction is not possible during initial ERCP, temporary plastic stent placement followed by definitive treatment within 4-6 weeks is recommended 1
The European Society of Gastrointestinal Endoscopy recommends that for large stones, endoscopic papillary balloon dilation as an adjunct to sphincterotomy is recommended to facilitate removal 2, 5
The British Society of Gastroenterology suggests that rectal NSAIDs should be administered to all patients undergoing ERCP to reduce the risk of post-ERCP pancreatitis, unless contraindicated 6
The European Society of Gastrointestinal Endoscopy recommends that in patients with high risk of post-ERCP pancreatitis due to repeated pancreatic duct cannulation, pancreatic stent placement should be considered in addition to rectal NSAIDs 5

The American Society of Clinical Oncology recommends that if pancreatic cancer is suspected, a multidisciplinary approach is required 7
The American Society of Clinical Oncology suggests that for biliary obstruction due to pancreatic cancer, endoscopic placement of a permanent self-expanding metal stent is preferred to achieve relief of jaundice and pruritus 7
The American Society of Clinical Oncology recommends that plastic stents can be considered for patients with expected survival less than 3 months 7

The British Society of Gastroenterology recommends that full blood count and INR/PT should be performed prior to ERCP with planned sphincterotomy 2, 5
The European Society of Gastrointestinal Endoscopy suggests that if coagulopathy is identified, management should follow locally agreed guidelines 5
The British Society of Gastroenterology recommends that patients taking anticoagulants or antiplatelet medications should be managed according to BSG and ESGE guidelines 5

The American Gastroenterological Association recommends that for patients with gallbladder in situ and choledocholithiasis, cholecystectomy should be performed after bile duct clearance, ideally within 2-4 weeks of successful ERCP 3, 1
The European Society of Gastrointestinal Endoscopy suggests that laparoscopic bile duct exploration is an equally effective alternative to perioperative ERCP, with the choice based on local expertise and resources 2, 1
The British Society of Gastroenterology recommends that for high surgical risk patients, biliary sphincterotomy and endoscopic duct clearance alone is an acceptable alternative 1

The World Journal of Emergency Surgery recommends that patients with temporary biliary stents should be monitored for signs of stent occlusion 1
The American Society of Clinical Oncology suggests that urgent biliary decompression is required for patients with acute cholangitis or septic shock 1
The World Journal of Emergency Surgery recommends that after discharge, follow-up imaging should be driven by clinical symptoms 4
The World Journal of Emergency Surgery suggests that CT scan is usually the first-line follow-up imaging tool for new-onset signs and symptoms in adults 4

The Journal of Clinical Oncology recommends that in patients with pancreatic enzyme deficiency causing malabsorption, pancreatic enzyme replacement therapy should be considered 7